Elisa Furay, MD1, SD Doggett, PA1, K Freeman, NP2, Francis P Buckley, MD1, R Bell, MD2. 1Dell Medical School at The University of Texas at Austin l, 2Institute for Esophageal and Reflux Surgery
Objective: Prospectively collected data from the Registry of Anti-Reflux Surgery (ROARS) were used to evaluate patient reported outcomes after laparoscopic magnetic sphincter augmentation (LMSA) and compare these to laparoscopic Nissen fundoplication (LNF), laparoscopic partial fundoplications (LPF), and all fundoplications (LNF+LPF).
Methods: The ROARS database is a prospectively collected multi-center quality registry. We prospectively evaluated 1173 patients undergoing either LMSA, LPF, or LNF. We compared each groups GERD-HRQL, regurgitation, dysphagia, and bloat scores preoperatively, at 6 months and at 1 year. Chronic acid suppression use at 6 months and 1 year postoperatively were compared. These variables were compared using a univariate analysis and statistical significance was determined by a p-value <0.05.
Results: Of a total of 1173 registry patients 638 underwent LMSA, 382 underwent LPF, and 153 underwent LNF. When comparing LMSA and LPF postoperative quality of life scores at 6 months and 1 year the LMSA had significantly improved 6 month and 1 year bloat score (0.89±1.1 versus 1.2±1.5; p= .02, 1.1±1.3 versus 1.9±1.7; p=.0001 respectively) and 1 year GERD-HQRL score (5.7±6.5 versus 8.6±9.1; p=.002). Comparing LMSA to LNF, the patients who underwent LNF had improved 6 month dysphagia score (1.8±2.2 versus .97±1.8; p=.04). Comparing LMSA to all fundoplications, LMSA had significantly improved 6 month and 1 year HQRL scores (5.2±6.7 versus 6.5±7.9; p=.47; 5.7±6.5 versus 8.2±8.9; p=.004 respectively), as well as 6 month and 1 year bloat scores (.89±1.1 versus 1.2±1.4 p=.02; 1.1±1.3 versus 1.7±1.6; p=.001 respectively). There was no difference in the use of chronic acid suppression at 6 month or 1 year when comparing LMSA to any fundoplication group.
Conclusion: Results from the ROARS database indicate that LMSA has improved or comparable quality of life metrics when compared to LPF, LNF and all fundoplications.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95563
Program Number: P472
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster